Specific gene variants in MIF and EPHX2 are independently associated with elevated susceptibility to multiple sclerosis, according to a case-control study conducted by researchers at Menoufia University. The investigation evaluated the influence of single nucleotide polymorphisms across the MIF, EPHX2, and BCHE genes on disease pathogenesis and clinical severity in patients diagnosed with the condition.
Multiple sclerosis is identified in the study as a chronic autoimmune disease affecting the central nervous system. The researchers note that the condition has an estimated global prevalence of 23.9 cases per 100,000 population, framing the ongoing research effort to identify specific genetic polymorphisms and circulating biological markers linked to disease development and patient prognosis.
The research was undertaken in collaboration between the Department of Medical Biochemistry and Molecular Biology within the Faculty of Medicine and the Faculty of Applied Health Sciences Technology at Menoufia University. The investigative framework compared two distinct participant cohorts: a primary group composed of patients diagnosed with multiple sclerosis and a second group comprising healthy controls matched for age, gender, and socioeconomic position who had no prior history of neurological or autoimmune disorders.
Genetic analyses revealed substantial risk increases associated with specific variants of the MIF and EPHX2 genes. Participants carrying the MIF GC and CC genotypes showed a 600 percent increase in multiple sclerosis risk compared to reference profiles. In parallel, individuals possessing the EPHX2 AG and GG genotypes demonstrated a 338.3 percent increase in disease risk. Subsequent multivariate analysis confirmed that both the MIF GC plus CC and EPHX2 AG plus GG genotypes functioned as independent predictors of multiple sclerosis.
The team observed a different dynamic when examining the BCHE gene polymorphism. The BCHE TT genotype did not achieve statistical significance regarding the onset or susceptibility to multiple sclerosis. However, the presence of the TT genotype was significantly linked to a worse clinical course among patients, showing a trend toward greater disease severity during the progression of the condition.
Beyond genetic markers, the investigators measured physiological parameters that demonstrated inverse relationships with multiple sclerosis risk. Multivariate assessments indicated that each unit rise in red blood cell count reduced the risk of multiple sclerosis by 71.3 percent. Similarly, each unit rise in vitamin D levels corresponded to a 29.5 percent reduction in disease risk among the evaluated participants.
The study authors concluded that while MIF and EPHX2 gene variants serve as independent indicators of susceptibility to multiple sclerosis, the BCHE TT genotype associates specifically with disease severity. Furthermore, the demonstrated protective associations linked to red blood cells and vitamin D highlight key biological pathways warranting future investigation.
Subject of Research: Genetic polymorphisms and biomarker associations in multiple sclerosis susceptibility and severity
Article Title: Influence of MIF, EPHX2, and BCHE gene polymorphisms on multiple sclerosis susceptibility and clinical severity
Article References: Ghobashy, E. A.-R., Badr, E. A. E., Salem, W. M., Hadhoud, M. M., & Saleh, M. (2026). Influence of MIF, EPHX2, and BCHE gene polymorphisms on multiple sclerosis susceptibility and clinical severity. Molecular Biology Reports, 53(1), Article 1987. https://doi.org/10.1007/s11033-026-12961-x
Image Credits: AI Generated
DOI: 10.1007/s11033-026-12961-x
Keywords: multiple sclerosis, MIF gene, EPHX2 gene, BCHE gene, single nucleotide polymorphisms, case-control study, autoimmune disease, central nervous system, vitamin D, red blood cells, disease susceptibility, clinical severity, Menoufia University, multivariate analysis, disease pathogenesis, prognosis
News Source: Juliet Wilcox. (November 19, 2026). MIF and EPHX2 Gene Variants Are Linked to Increased Multiple Sclerosis Risk. Scienmag.



